Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Improving Hypertension Medication Adherence for Older Adults
Authors not listed
University of Arizona · 2022
Abstract
This randomized controlled trial will assess the efficacy and scalability of a blood pressure technology system intervention. The investigators will enroll 224 older adults with hypertension to identify those who are nonadherent for one hypertension medication. The participants will be randomized to one of two groups (112 per group) to use the blood pressure system for 6-months. Both groups receive information about high blood pressure and medications. One group will also receive strategies that can be used to take medications and manage blood pressure. Both groups will complete a mid-assessment at 3-months and a post-assessment at 6-months.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Anonymous. (2022). Improving Hypertension Medication Adherence for Older Adults. <em>University of Arizona</em>. https://clinicaltrials.gov/study/NCT05610059
Vancouver
Anonymous. Improving Hypertension Medication Adherence for Older Adults. University of Arizona. 2022.
BibTeX
@misc{anon2022Improv,
title = {Improving Hypertension Medication Adherence for Older Adults},
author = {Anonymous},
journal = {University of Arizona},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Arizona 2024
Open access · US-GOV
Digital Technology to Support Adherence to Hypertension Medications for Older Adults With Mild Cognitive Impairment
National Taipei University 2026
Open access · US-GOV
Dose-Response Effects of Velocity-Based Resistance Training on Anti-Inflammatory Responses in Older Adults
CanSino Biologics Inc. 2024
Open access · US-GOV
A Randomized, Observer-Blind, Positive-controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults Aged 18-54 Years
Kaiser Permanente 2019
Open access · US-GOV
Randomized Trial to Reduce Sitting Time and Improve Cardiometabolic Health in Obese Older Adults
Beijing BeneWill Technology Development Co., Ltd 2026
Open access · US-GOV
Phase III Multicenter, Randomized, Blinded, Placebo-controlled Trial Assessing the Efficacy, Safety, and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Adults Aged ≥60 Years
Hebrew SeniorLife 2019
Open access · US-GOV